These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26012902)

  • 1. Reduction in broad-spectrum Gram-negative agents by diverse prescribing of aztreonam within NHS Tayside.
    Kennedy H; Wilson S; Marwick C; Malcolm W; Nathwani D
    J Antimicrob Chemother; 2015 Aug; 70(8):2421-3. PubMed ID: 26012902
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of antibiotic resistance and its audit in our country: how to develop an antibiotic policy.
    Wattal C
    Indian J Med Microbiol; 2012; 30(4):381-3. PubMed ID: 23183459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and public health challenge of Gram-negative resistance in Australasia.
    Gilroy N; Iredell J
    Future Microbiol; 2014; 9(1):17-20. PubMed ID: 24328377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam treatment of neonatal sepsis.
    Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hatziioannidis K; Tsurutsoglu G
    J Chemother; 1989 Jul; 1(4 Suppl):687-8. PubMed ID: 16312593
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic stewardship programmes and the surgeon's role.
    Çakmakçi M
    J Hosp Infect; 2015 Apr; 89(4):264-6. PubMed ID: 25744279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time series analysis of the impact of an intervention in Tayside, Scotland to reduce primary care broad-spectrum antimicrobial use.
    Hernandez-Santiago V; Marwick CA; Patton A; Davey PG; Donnan PT; Guthrie B
    J Antimicrob Chemother; 2015 Aug; 70(8):2397-404. PubMed ID: 25953807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital.
    Di Pentima MC; Chan S
    Pediatr Infect Dis J; 2010 Aug; 29(8):707-11. PubMed ID: 20182398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial stewardship education for medical students.
    Luther VP; Ohl CA; Hicks LA
    Clin Infect Dis; 2013 Nov; 57(9):1366. PubMed ID: 23893971
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic policy.
    Gyssens IC
    Int J Antimicrob Agents; 2011 Dec; 38 Suppl():11-20. PubMed ID: 22018989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aztreonam--new antibiotic for treating infections caused by gram-negative aerobic bacteria].
    Szymkowiak J; Fojt E
    Wiad Lek; 1993; 46(1-2):56-61. PubMed ID: 8249381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09.
    Shapiro DJ; Hicks LA; Pavia AT; Hersh AL
    J Antimicrob Chemother; 2014 Jan; 69(1):234-40. PubMed ID: 23887867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aztreonam.
    Cunha BA
    Urology; 1993 Mar; 41(3):249-58. PubMed ID: 8442309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections.
    Dortch MJ; Fleming SB; Kauffmann RM; Dossett LA; Talbot TR; May AK
    Surg Infect (Larchmt); 2011 Feb; 12(1):15-25. PubMed ID: 21091186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance: the perfect storm.
    Gould IM
    Int J Antimicrob Agents; 2009 Aug; 34 Suppl 3():S2-5. PubMed ID: 19596110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria.
    Antoniadou A; Kanellakopoulou K; Kanellopoulou M; Polemis M; Koratzanis G; Papademetriou E; Poulakou G; Giannitsioti E; Souli M; Vatopoulos A; Giamarellou H
    Scand J Infect Dis; 2013 Jun; 45(6):438-45. PubMed ID: 23336730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UTIs and two new antibiotics in the elderly.
    Jones SR; Kimbrough R
    Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Delhi metallo-β-lactamase (NDM-1): an update.
    Shakil S; Azhar EI; Tabrez S; Kamal MA; Jabir NR; Abuzenadah AM; Damanhouri GA; Alam Q
    J Chemother; 2011 Oct; 23(5):263-5. PubMed ID: 22005056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aztreonam.
    Johnson DH; Cunha BA
    Med Clin North Am; 1995 Jul; 79(4):733-43. PubMed ID: 7791420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.